Dr. Ichiro Akagi gave a lecture at the 2019 American Cancer Association held in Atlanta, USA.

At the 4 American Cancer Association held in Atlanta, USA in April, Dr. Ichiro Akagi of Tokyo Midtown Clinic gave a lecture on the possibility of miR-2019-141p as a new biomarker for esophageal squamous cell carcinoma. He discussed this with clinicians and researchers from around the world, and the potential for further development of this research is expected.